|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of goods sold | ||||
| Cost of Revenue | ||||
| Gross Profit | ||||
| General and Administrative Expenses | ||||
| Loss on Impairment of Intangible Assets | ||||
| Total operating expenses | ||||
| Loss From Operations | ||||
| Other Income (Expense) | ||||
| Interest income | ||||
| Business reassessment and repositioning adjustments | ||||
| Gain on acquisition | ||||
| Interest expense | ||||
| Financial expenses | ||||
| Change in fair value of derivative liabilities | ||||
| Other income (expenses) | ||||
| Legal settlement | ||||
| Other income (expense) | ||||
| PPP loan forgiveness | ||||
| Other income (expense) (net) | ||||
| Net loss | ||||
| Net Income (Loss) From Continuing Operations Including Non-Controlling Interest | ||||
| Discontinued Operations | ||||
| Net Income (Loss) From Discontinued Operations | ||||
| Net Income | ||||
| Net Income (Loss) Including Non-Controlling Interest | ||||
| Non-Controlling Interest | ||||
| Net Income (Loss) Available to Common Shareholders | ||||
| Basic | ||||
| Loss per share - basic and diluted | ||||
| From Continuing Operations | ||||
| From Discontinued Operations | ||||
| Attributable To Common Shareholders | ||||
| Weighted Average Number of Common Shares Outstanding - Basic and Diluted | ||||
Loading...